Beam Therapeutics BEAM
NASDAQ BEAM
$24.39 -0.06 (-0.25%)
At close: Oct 1, 2026 · 4:00 PM EDT

Beam Therapeutics (BEAM) Long-Term Debt Issuances (2020 - 2026)

Updated

Beam Therapeutics' Long-Term Debt Issuances was $93.89 million in Q1 2026.

Analysis

Beam Therapeutics (BEAM) Long-Term Debt Issuances (2020 - 2026) Analysis & Trends

For FY2020, Long-Term Debt Issuances at Beam Therapeutics came in at $3.27 million, down 47.1% from FY2019.

  • In earlier years, Long-Term Debt Issuances was $6.18 million in FY2019.
  • The Q1 2026 figure marks the lowest quarterly Long-Term Debt Issuances since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.98 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Beam Therapeutics 2.52 Bn 2.52 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 93.89 Mn
Dec 31, 2020 1.64 Mn
API Access

Beam Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=BEAM&period=max&api_key=YOUR_API_KEY